The global single-cell analysis market size is expected to reach USD 6.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.0% from 2021 to 2028. Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell.
Single-cell technology helps in assessing cellular heterogeneity and aids in the analysis of pathways and processes at the molecular level. This technology is evolving at a rapid pace with applications in oncology, immunology, and others. Moreover, the introduction of advanced devices that simplify transcriptomic and proteomics procedures is driving the market.
Advances in single-cell RNA sequencing (scRNAseq) allow researchers to thoroughly investigate unexplored rare cell types. The development of the microfluidics method has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field. A substantial number of microfluidic devices have been modified for cell dissociation and tissue digestion.
The increasing number of research publications is representative of the increasing investment flow in R&D in this market. As the R&D activities are the base of innovation, these investments signify a healthy growth possibility for this market. Moreover, researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level; thus, are anticipated to boost the uptake of consumables and instruments for the analysis.
Request a free sample copy or view report summary: Single-cell Analysis Market Report
The consumables segment accounted for the largest revenue share due to the high adoption and demand of products offered under this segment
Given the wide availability of different forms of reagents, this segment is responsible for constant revenue generation
Owing to the high-end features and the technically advanced analytical options, automated instruments contributed to maximum revenue share
The oncology segment is majorly benefited by the advancements in single-cell analysis methods
To avoid risks associated with cancer therapy, single-cell analysis techniques are being heavily adopted for cancer genomics
There is increasing demand for prenatal diagnosis and non-invasive techniques for the detection of single-gene disorders associated with the fetus
This has increased the adoption of single-cell analysis for prenatal diagnosis
Single-cell analysis is being widely employed by various end-users, ranging from academic research institutes to biotechnology and pharmaceutical companies
Academic and research institutes held a significant share due to wide usage across various studies
North America dominated the 2020 global market owing to the increasing R&D of robust therapies and disease diagnosis
Asia-Pacific is projected to witness the fastest CAGR, with India and China at the forefront
Thermo Fisher Scientific, QIAGEN NV, Illumina Inc., Merck Millipore, BGI, Fluidigm Corporation, and Bio-Rad Laboratories are some prominent entities in this space.
Companies have focused on the development of new innovative products to gain a competitive advantage
Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region:
Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)
High Content Screening Systems
Single Live Cell Imaging
Automated Cell Counters
Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 - 2028)
Non-invasive prenatal diagnosis
Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028)
Single-cell isolation & Library Preparation
Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028)
Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)
Middle East & Africa (MEA)
List of Key Players of Single-cell Analysis Market
Thermo Fisher Scientific
10x Genomics Inc.
Becton, Dickinson & Company
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."